Antiproliferative Activities of Parthenolide and Golden Feverfew Extract Against Three Human Cancer Cell Lines
Authors:
- 1 March 2006
- journal article
- research article
- Published by SAGE Publications in Journal of Medicinal Food
- Vol. 9 (1) , 55-61
Abstract
The medicinal herb feverfew [Tanacetum parthenium (L.) Schultz-Bip.] has long been used as a folk remedy for the treatment of migraine and arthritis. Parthenolide, a sesquiterpene lactone, is considered to be the primary bioactive compound in feverfew having anti-migraine, anti-tumor, and anti-inflammatory properties. In this study we determined, through in vitro bioassays, the inhibitory activity of parthenolide and golden feverfew extract against two human breast cancer cell lines (Hs605T and MCF-7) and one human cervical cancer cell line (SiHa). Feverfew ethanolic extract inhibited the growth of all three types of cancer cells with a half-effective concentration (EC50) of 1.5 mg/mL against Hs605T, 2.1 mg/mL against MCF-7, and 0.6 mg/mL against SiHa. Among the tested constituents of feverfew (i.e., parthenolide, camphor, luteolin, and apigenin), parthenolide showed the highest inhibitory effect with an EC50 against Hs605T, MCF-7, and SiHa of 2.6 µg/mL, 2.8 µg/mL, and 2.7 µg/mL, respectively. Interactions between parthenolide and flavonoids (apigenin and luteolin) in feverfew extract also were investigated to elucidate possible synergistic or antagonistic effects. The results revealed that apigenin and luteolin might have moderate to weak synergistic effects with parthenolide on the inhibition of cancer cell growth of Hs605T, MCF-7, and SiHa.Keywords
This publication has 29 references indexed in Scilit:
- The anti-inflammatory sesquiterpene lactone parthenolide suppresses CD95-mediated activation-induced-cell-death in T-cellsCell Death & Differentiation, 2002
- Enhancement of 1α,25‐dihydroxyvitamin D3‐induced differentiation of human leukaemia HL‐60 cells into monocytes by parthenolide via inhibition of NF‐κB activityBritish Journal of Pharmacology, 2002
- INHIBITION OF ENVIRONMENTAL ESTROGEN–INDUCED PROLIFERATION OF HUMAN BREAST CARCINOMA MCF-7 CELLS BY FLAVONOIDSIn Vitro Cellular & Developmental Biology - Animal, 2001
- Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolideOncogene, 2000
- Low Concentrations of the Feverfew Component Parthenolide Inhibit In Vitro Growth of Tumor Lines in a Cytostatic FashionPlanta Medica, 1999
- Sesquiterpene lactones from feverfew, Tanacetum parthenium: isolation, structural revision, activity against human blood platelet function and implications for migraine therapyJournal of the Chemical Society, Perkin Transactions 1, 1996
- A Comparison of the Effects of an Extract of Feverfew and Parthenolide, a Component of Feverfew, on Human Platelet Activity In-vitroJournal of Pharmacy and Pharmacology, 1990
- RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTIONThe Lancet, 1988
- Compounds extracted from feverfew that have anti-secretory activity contain an α-methylene butyrolactone unitJournal of Pharmacy and Pharmacology, 1986
- Cytotoxic Agents from Michelia champaca and Talauma ovata: Parthenolide and CostunolideJournal of Pharmaceutical Sciences, 1977